Table 2.
Baseline demographic and clinical characteristics of patients
| Type of preparation | P‐value | ||
|---|---|---|---|
| WD/PICO (n = 125) | CF/PEG + SPMC (n = 125) | ||
| Age (year), mean ± SD | 54.5 ± 13.4 | 54.0 ± 13.1 | 0.81 |
| Male gender, n (%) | 70 (56) | 65 (52) | 0.53 |
| Weight (kg), mean ± SD | 79.2 ± 15.7 (n = 94) |
77.3 ± 19.4 (n = 99) |
0.45 |
| Height (cm), mean ± SD | 171.4 ± 10.3 (n = 91) |
169.8 ± 14.4 (n = 99) |
0.36 |
| Diabetes, n (%) | 6 (5.6) (n = 107) |
5 (4.4) (n = 113) |
0.69 |
| Opioids, n (%) | 16 (15.2) (n = 105) |
14 (12.5) (n = 112) |
0.56 |
| Laxative use, n (%) | 11 (10.3) (n = 107) |
15 (13.4) (n = 112) |
0.48 |
CF, clear fluid; PEG, polyethylene glycol; PICO, picosalax; SPMC, sodium picosulfate/magnesium citrate; WD, White Diet.